Press releases
- Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
- Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
- Gabather reports initial positive results from the EEG/fMRI target engagement study
Key statistics
As of last trade, Gabather AB (5J2:FRA) traded at 0.0964, 232.41% above the 52 week low of 0.029 set on Feb 28, 2024.
52-week range
Open | 0.1005 |
---|---|
High | 0.1005 |
Low | 0.0964 |
Bid | 0.104 |
Offer | 0.172 |
Previous close | 0.0902 |
Average volume | 0.00 |
---|---|
Shares outstanding | 18.10m |
Free float | 17.30m |
P/E (TTM) | -- |
Market cap | 28.59m SEK |
EPS (TTM) | -0.652 SEK |
Data delayed at least 15 minutes, as of Apr 25 2024 08:20 BST.
More ▼